Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Clavis Pharma Study Completion

October 24, 2011 12:11 pm | News | Comments

Clavis Pharma announces the cut-off level for defining hENT1 low verse high expression for assessing the results from the LEAP trial with CP-4126 in pancreatic cancer patients.


Non-Hodgkin Lymphoma Risk Factors Include Diet

October 24, 2011 12:04 pm | News | Comments

Young adulthood body weight and diet appear to be associated with the risk for non-Hodgkin lymphoma.


RNA-Seq Solutions

October 24, 2011 7:56 am | Product Releases | Comments

Appistry, Inc. announced the release of a series of advanced RNA-Seq solutions for the rapid analysis of sequencing data generated by this emerging technology.


Dissolution Apparatus

October 24, 2011 7:48 am | Product Releases | Comments

Agilent Technologies Inc. has introduced the 709-DS Dissolution Apparatus, which features a bath-free design that provides an unobstructed view of the dissolution vessel.


Amgen Working with Freeslate on Protein Drugs

October 24, 2011 7:33 am | News | Comments

Freeslate, Inc. announced that Amgen, Inc. has entered into a collaborative relationship with the company to leverage Freeslate solutions in addressing aggregation and particulation in protein drug products.


DFMO May Become Skin Cancer Treatment

October 24, 2011 7:28 am | News | Comments

Researchers found that DFMO, or ?-difluoromethylornithine, still appeared to protect against nonmelanoma skin cancers years after people stopped taking the drug.


BG-12 Performs Well in Late-Stage Trial

October 24, 2011 7:25 am | News | Comments

Biogen Idec announced positive data from the Phase 3 DEFINE clinical trial of oral BG-12 in people with relapsing-remitting multiple sclerosis.


CHMP Issues Positive Opinion on Bronchitol

October 24, 2011 7:19 am | News | Comments

Pharmaceutical company Pharmaxis announced the Committee for Medicinal Products for Human Use has adopted a positive opinion recommending the granting of a Marketing Authorization for Bronchitol, a cystic fibrosis treatment.


Amag-Allos Deal Called Off

October 24, 2011 7:07 am | News | Comments

Amag Pharmaceuticals Inc. will not acquire lymphoma drug maker Allos Therapeutics Inc., as Amag's shareholders voted down the deal. Amag said its shareholders voted against issuing new stock.


Humalog on Par with Older Treatments

October 24, 2011 7:05 am | News | Comments

Halozyme Therapeutics Inc. said that two clinical trials showed its "ultrafast" insulin worked as well as an older insulin replacement for patients with both type 1 and type 2 diabetes.


Biogen-Abbott MS Drug Outperforms Placebo

October 24, 2011 6:52 am | News | Comments

Biogen Idec and Abbott Laboratories said a mid-stage study of their multiple sclerosis medicine daclizumab showed that the experimental drug worked better than placebo at preventing relapse of symptoms of the inflammatory disease.


Development of Autistic Brains Versus Healthy Brains

October 21, 2011 12:04 pm | News | Comments

Researchers at UCLA have found a possible explanation for why autistic children act and think differently than their peers.


Lisdexamfetamine Dimesylate Proves Effective for ADHD

October 21, 2011 12:00 pm | News | Comments

Shire announced positive results of a European Phase 3 study of once-daily lisdexamfetamine dimesylate in children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder.


Target Identified To Decrease Triglycerides, Increase Cholesterol

October 21, 2011 11:32 am | News | Comments

Researchers announce findings that show the inhibition of both microRNA-33a and microRNA-33b with chemically modified anti-miR oligonucleotides suppress triglyceride levels and cause an increase in high density lipoprotein cholesterol.


Barcoded Tubes

October 21, 2011 8:05 am | Product Releases | Comments

Thermo Fisher Scientific Inc. introduced its Matrix Amber 2D barcoded tubes, expanding its sizeable sample storage product portfolio to offer protection of light-sensitive samples.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.